A Multiple-dose Study of Gantenerumab in Japanese Alzheimer's Disease Patients

This study is currently recruiting participants.
Verified August 2013 by Chugai Pharmaceutical
Sponsor:
Information provided by (Responsible Party):
Chugai Pharmaceutical
ClinicalTrials.gov Identifier:
NCT01656525
First received: June 5, 2012
Last updated: August 6, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)